A Phase 1b Clinical Trial of Dacetuzumab in Combination with Rituximab and Gemcitabine: Multiple Responses Observed in Patients with Relapsed Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Forero-Torres, Andres [1 ]
Bartlett, Nancy L. [2 ]
Nasta, Sunita D. [3 ]
Northfelt, Donald [4 ]
Beaven, Anne [5 ]
Myint, Han [6 ]
Whiting, Nancy C. [7 ]
Drachman, Jonathan G. [7 ]
Moskowitz, Craig H. [8 ]
机构：
[1] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[2] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA
[3] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[4] Mayo Clin Arizona, Scottsdale, AZ USA
[5] Duke Univ, Med Ctr, Durham, NC USA
[6] Univ Colorado, Aurora, CO USA
[7] Seattle Genet Inc, Bothell, WA USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [1] Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma
    Forero-Torres, Andres
    Bartlett, Nancy
    Beaven, Anne
    Myint, Han
    Nasta, Sunita
    Northfelt, Donald W.
    Whiting, Nancy C.
    Drachman, Jonathan G.
    LoBuglio, Albert F.
    Moskowitz, Craig H.
    LEUKEMIA & LYMPHOMA, 2013, 54 (02) : 277 - 283
  • [2] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Stefoni, Vittorio
    Quirini, Federica
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Baccarani, Michele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06): : 462 - 466
  • [3] Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
    Petrillo, Alessandra
    Ip, Andrew
    Della Pia, Alexandra
    Gill, Sarvainder
    Zenreich, Joshua
    Gutierrez, Martin
    McNeill, Ann
    Feldman, Tatyana
    Leslie, Lori A.
    Goy, Andre
    HEMASPHERE, 2022, 6 (06):
  • [4] Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study
    Palomba, M. Lia
    Till, Brian G.
    Park, Steven I.
    Morschhauser, Franck
    Cartron, Guillaume
    Marks, Reinhard
    Shivhare, Mahesh
    Hong, Wan-Jen
    Raval, Aparna
    Chang, Alice C.
    Penuel, Elicia
    Popplewell, Leslie L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E443 - E451
  • [5] Use of gemcitabine, cisplatin and methylprednisolone with or without rituximab in relapsed and refractory patients with diffuse large B-cell lymphoma
    Sirohi, B
    Cunningham, D
    Norman, A
    Trumper, M
    Prior, Y
    Last, K
    Chong, G
    Horwich, A
    Wotherspoon, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [6] A phase III trial evaluating glofitamab in combination with gemcitabine plus oxaliplatin versus rituximab in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Hertzberg, Mark
    Ku, Matthew
    Catalani, Olivier
    Althaus, Betsy
    Simko, Stephen
    Gregory, Gareth P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Bendamustine/rituximab in relapsed or refractory diffuse large B-cell lymphoma
    Vacirca, J. L.
    Acs, P. I.
    Shimkus, B. J.
    Rosen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Phase III trial of bendamustine plus rituximab for relapsed or refractory diffuse large B-cell lymphoma in Japan
    Kiguchi, Toru
    Terui, Yasuhito
    Izutsu, Koji
    Kameoka, Yoshihiro
    Hidaka, Michihiro
    Kato, Harumi
    Matsumura, Itaru
    Kuroda, Junya
    Ishizawa, Kenichi
    Ichikawa, Satoshi
    Ando, Kiyoshi
    Ogura, Michinori
    Tobinai, Kensei
    Fukushima, Koji
    Murayama, Kayoko
    ANNALS OF ONCOLOGY, 2021, 32 : S304 - S304
  • [9] A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma
    Park, Steven I.
    Grover, Natalie S.
    Olajide, Oludamilola
    Asch, Adam S.
    Wall, James G.
    Richards, Kristy L.
    Sobol, Anna L.
    Deal, Allison M.
    Ivanova, Anastasia
    Foster, Matthew C.
    Muss, Hyman B.
    Shea, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 281 - 289
  • [10] Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
    Assouline, Sarit E.
    Nielsen, Torsten Holm
    Yu, Stephen
    Alcaide, Miguel
    Chong, Lauren
    MacDonald, David
    Tosikyan, Axel
    Kukreti, Vishal
    Kezouh, Abbas
    Petrogiannis-Haliotis, Tina
    Albuquerque, Marco
    Fornika, Daniel
    Alamouti, Sepideh
    Froment, Remi
    Greenwood, Celia M. T.
    Oros, Kathleen Klein
    Camglioglu, Errol
    Sharma, Ayushi
    Christodoulopoulos, Rosa
    Rousseau, Caroline
    Johnson, Nathalie
    Crump, Michael
    Morin, Ryan D.
    Mann, Koren K.
    BLOOD, 2016, 128 (02) : 185 - 194
12345